Press Releases

Poxel Reports Results for Fiscal Year 2015 and Provides Corporate Update

Apr 1, 2016

Poxel has been Granted U.S. Composition of Matter Patent for Direct AMPK Activator PXL770 for the Potential Treatment of Type 2 Diabetes and Related Disorders

Mar 29, 2016

Poxel Appoints Jonae R. Barnes as Senior Vice President Investor Relations and Public Relations, Based in Boston

Mar 14, 2016

Poxel to Present at 28th Annual ROTH Conference

Mar 4, 2016

Poxel Appoints Janice Bourque and Pierre Legault to its Board of Directors

Feb 1, 2016

Poxel Provides YE15 Cash and Turnover Figures

Jan 28, 2016

Poxel Announces its 2016 Financial Calendar

Jan 4, 2016

Poxel Announces Imeglimin Phase 2b Initiation in Japan

Dec 14, 2015

Poxel Presents New Data on Imeglimin and PXL770 at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Diseases in Los Angeles

Nov 23, 2015

POXEL Announces Patent Access Agreement with ENYO

Nov 17, 2015